Greencare Capital - Notice of AGM
RNS Number : 6836O
Greencare Capital PLC
13 June 2022
 

13 June 2022

 

Greencare Capital plc

("Greencare" or "the Company")

Notice of AGM

Greencare (AQUIS: GRE), the investment company focused on investing in medicinal cannabis, CBD and related areas, announces that the Company's Annual General Meeting ("AGM") will be held at 10.00 a.m. on Thursday, 7 July 2022 at 50 Sloane Avenue, London, SW3 3DD.

The Notice of AGM (the "Notice"), including a Letter from the Company's Chairman, Dominic White  and Form of Proxy have been sent to shareholders and will shortly be available on the Company's website, www.greencare.capital.

Shareholders are encouraged to complete, sign and return the Form of Proxy accompanying the Notice to the Company's Registrar, Share Registrars Limited, as soon as possible, but in any event so as to be received not later than 10.00 a.m. on 5 July 2022. The return of a Form of Proxy will not preclude a shareholder from attending and voting at the Annual General Meeting in person, should they subsequently decide to do so.

 

Enquiries:

 

Greencare Capital plc

Dominic White/Martin Walton

 

c/o Walbrook PR Ltd

 

Cairn Financial Advisers LLP

AQSE Corporate Adviser

Jo Turner / James Lewis

 

+44 (0)20 7213 0885

 

 

  

Walbrook PR Limited

Paul Vann/Joe Walker

 

+44 (0)20 7933 8780

+44 (0)7768 807631

greencarecapital@walbrookpr.com

 

Notes:

Greencare Capital plc is an investment company quoted on the Aquis Stock Exchange Growth Market ("AQSE"). The Company was incorporated on 1 October 2019 and its shares were admitted to trading on 30 December 2019.

 

The Company's investment strategy is to focus on investments in cannabis sectors within countries predominantly in Europe whose jurisdictions have well-developed and reputable laws and regulations for its production, research and distribution; together with the CBD and hemp sectors.

 

The Company will invest directly or indirectly in public or private companies, in supply and distribution chains, or other business associated with the cannabis sector. Investments may take the form of debt or equity and it is expected that such investments will ordinarily seek capital growth in the medium term in preference to income.

 

The Company will not invest in the recreational cannabis sector, or in entities or activities supported by it, nor any other related activities which would be deemed illegal under UK legislation.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXUOVURUNUNAAR ]]>